- Home
- MNOV vs ZEPP Comparison
MNOV vs ZEPP Comparison
Compare MNOV & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNOV | ZEPP |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 71.9M |
| IPO Year | 2004 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MNOV | ZEPP |
|---|---|---|
| Price | $1.34 | $4.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 37.0K | 33.7K |
| Earning Date | 05-14-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,360,807.00 | N/A |
| Revenue This Year | N/A | $778.34 |
| Revenue Next Year | $180.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.17 | $3.85 |
| 52 Week High | $1.96 | $61.50 |
Technical Indicators
Market Signals| Indicator | MNOV | ZEPP |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 32.31 |
| Support Level | $1.24 | $4.02 |
| Resistance Level | $1.46 | $5.63 |
| Average True Range (ATR) | 0.04 | 0.41 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 6.67 | 16.03 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.